Application 013217
- Type
- NDA
- Sponsor
- KING PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SKELAXIN | METAXALONE | TABLET;ORAL | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 003 | SKELAXIN | METAXALONE | TABLET;ORAL | 800MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N013217-001 | SKELAXIN | METAXALONE | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | ||
| N013217-003 | SKELAXIN | METAXALONE | 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-08-30 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N013217-003 | 7122566 | 2026-02-06 | U-915 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N013217-001 | SKELAXIN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N013217-003 | SKELAXIN | 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-08-30 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N013217-001 | SKELAXIN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N013217-003 | SKELAXIN | 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-08-30 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N013217-001 | SKELAXIN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N013217-003 | SKELAXIN | 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-08-30 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N013217-001 | SKELAXIN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N013217-003 | SKELAXIN | 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-08-30 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N013217-001 | SKELAXIN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N013217-003 | SKELAXIN | 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-08-30 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N013217-001 | SKELAXIN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N013217-003 | SKELAXIN | 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-08-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N013217-001 | SKELAXIN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N013217-003 | SKELAXIN | 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-08-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N013217-001 | SKELAXIN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N013217-003 | SKELAXIN | 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-08-30 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N013217-001 | SKELAXIN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N013217-003 | SKELAXIN | 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-08-30 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N013217-001 | SKELAXIN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N013217-003 | SKELAXIN | 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-08-30 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N013217-001 | SKELAXIN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N013217-003 | SKELAXIN | 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-08-30 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N013217-001 | SKELAXIN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N013217-003 | SKELAXIN | 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-08-30 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N013217-001 | SKELAXIN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N013217-003 | SKELAXIN | 800MG | TABLET / ORAL | RLD | 2002-08-30 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N013217-001 | SKELAXIN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N013217-003 | SKELAXIN | 800MG | TABLET / ORAL | RLD | 2002-08-30 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N013217-001 | SKELAXIN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N013217-003 | SKELAXIN | 800MG | TABLET / ORAL | RLD | 2002-08-30 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N013217-001 | SKELAXIN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N013217-003 | SKELAXIN | 800MG | TABLET / ORAL | RLD | 2002-08-30 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N013217-001 | SKELAXIN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N013217-003 | SKELAXIN | 800MG | TABLET / ORAL | AB | RLD, RS | 2002-08-30 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N013217-001 | SKELAXIN | 400MG | TABLET / ORAL | RLD, Approved before 1982 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N013217-003 | SKELAXIN | 800MG | TABLET / ORAL | AB | RLD, RS | 2002-08-30 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N013217-001 | SKELAXIN | 400MG | TABLET / ORAL | RLD, Approved before 1982 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N013217-003 | SKELAXIN | 800MG | TABLET / ORAL | AB | RLD, RS | 2002-08-30 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N013217-001 | SKELAXIN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD, Approved before 1982 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N013217-003 | SKELAXIN | 800MG | TABLET / ORAL | AB | RLD, RS | 2002-08-30 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N013217-003 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N013217-003 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N013217-003 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N013217-003 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N013217-003 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N013217-003 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N013217-003 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N013217-003 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N013217-003 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N013217-003 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N013217-003 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N013217-003 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N013217-003 | AB | 1 | ea99ee380514… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N013217-003 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N013217-003 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N013217-003 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N013217-003 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N013217-003 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N013217-003 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N013217-003 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N013217-003 | AB | 1 | cb3db0bc1861… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N013217-003 | 7122566 | 2026-02-06 | U-915 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N013217-003 | 7122566 | 2026-02-06 | U-915 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N013217-003 | 7122566 | 2026-02-06 | U-915 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N013217-003 | 7122566 | 2026-02-06 | U-915 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N013217-003 | 7122566 | 2026-02-06 | U-915 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N013217-003 | 7714006 | 2021-12-03 | U-1050 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N013217-003 | 7122566 | 2026-02-06 | U-915 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N013217-003 | 7714006 | 2021-12-03 | U-1050 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N013217-003 | 7714006 | 2021-12-03 | U-1050 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N013217-003 | 7714006 | 2021-12-03 | U-1050 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N013217-003 | 7714006 | 2021-12-03 | U-1050 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N013217-003 | 7714006 | 2021-12-03 | U-1050 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N013217-003 | 7122566 | 2026-02-06 | U-915 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N013217-003 | 7714006 | 2021-12-03 | U-1050 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N013217-003 | 7714006 | 2021-12-03 | U-1050 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N013217-003 | 7122566 | 2026-02-06 | U-915 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N013217-003 | 7714006 | 2021-12-03 | U-1050 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N013217-003 | 7122566 | 2026-02-06 | U-915 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N013217-003 | 7122566 | 2026-02-06 | U-915 | 1c564ffb4f44… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metaxalone | METAXALONE | Northwind Health Company, LLC | d9cefc55-7643-ce9b-e053-2a95a90aff12 | 2026-01-01 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | Northwind Health Company, LLC | f2b46d69-1c20-5ae9-e053-2a95a90a60a9 | 2026-01-01 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | A-S Medication Solutions | d4caa7c6-afb5-43a2-ba38-cf30106b1d62 | 2025-12-05 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | AvPAK | 9b21a974-6a5a-9efb-e9de-470363217126 | 2025-11-26 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | PHOENIX RX LLC | 3a7c8b4d-7add-cb31-e063-6294a90a37f8 | 2025-10-21 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | PHOENIX RX LLC | 413b300d-4163-afef-e063-6394a90a618f | 2025-10-15 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | Actavis Pharma, Inc. | b3a4f6bc-abd4-4b8e-970f-59b3aa6f17a0 | 2025-07-30 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | BluePoint Laboratories | c91c0fb0-0b61-4e45-8bea-d0bf57ca7068 | 2025-07-07 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | Advanced Rx of Tennessee, LLC | 36c1d263-48ce-831b-e063-6394a90a0a2b | 2025-05-29 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | Amneal Pharmaceuticals LLC | 3aa9dba9-29b0-4520-a0f7-66d19d52c6bc | 2025-03-28 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | Major Pharmaceuticals | 8c1e10fe-0330-4bf8-a94d-aeed80f6aef1 | 2025-03-03 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | PD-Rx Pharmaceuticals, Inc. | edc6ba8d-2d45-4833-8dc7-e2d4e5d72856 | 2025-02-04 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | Dr. Reddys Laboratories Limited | 02eb5938-cd59-4a81-853d-a4148d813a94 | 2025-01-20 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | Advanced Rx of Tennessee, LLC | b3279496-293e-7e1f-e053-2a95a90ab506 | 2024-12-31 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | Advanced Rx Pharmacy of Tennessee, LLC | bd1c9022-aadc-af1f-e053-2995a90a0b42 | 2024-12-31 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | Advanced Rx Pharmacy of Tennessee, LLC | b713a0f2-d47a-0ae7-e053-2995a90a5b85 | 2024-12-31 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | Quality Care Products, LLC | f05bb280-6736-4215-be5b-0e5f7991cd87 | 2024-12-17 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | Bryant Ranch Prepack | a12304b7-6477-4518-8db5-898879c62caf | 2024-11-13 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | Bryant Ranch Prepack | c2dd7071-cba3-410c-ade5-9d7e5af42038 | 2024-09-16 | Warnings, Adverse reactions | METAXALONE |
| Metaxalone | METAXALONE | Amneal Pharmaceuticals of New York LLC | de3448df-4ca1-44ec-bad1-486549cddf64 | 2024-08-30 | Warnings, Adverse reactions | METAXALONE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0115-1748 | Metaxalone | Metaxalone | Impax Generics | NDA | Current |
| 0115-1748 | Metaxalone | Metaxalone | Amneal Pharmaceuticals of New York LLC | NDA | Current |
| 0115-1748 | Metaxalone | Metaxalone | Amneal Pharmaceuticals of New York LLC | NDA | Current |
| 10544-002 | Metaxalone | Metaxalone | Blenheim Pharmacal, Inc. | NDA | Current |
| 10544-524 | SKELAXIN | metaxalone | Blenheim Pharmacal, Inc. | NDA | Current |
| 21695-123 | Skelaxin | Metaxalone | Rebel Distributors Corp | NDA | Current |
| 35356-570 | Metaxalone | Metaxalone | Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC | NDA | Current |
| 42254-040 | Metaxalone | Metaxalone | Rebel Distributors Corp | NDA | Current |
| 43063-239 | Metaxalone | Metaxalone | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-239 | Metaxalone | Metaxalone | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-239 | Metaxalone | Metaxalone | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-239 | Metaxalone | Metaxalone | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-581 | Metaxalone | Metaxalone | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 50436-3024 | Metaxalone | Metaxalone | Unit Dose Services | NDA | Current |
| 51655-163 | Metaxalone | Metaxalone | Northwind Pharmaceuticals | NDA | Current |
| 52959-596 | Metaxalone | Metaxalone | H.J. Harkins Company, Inc. | NDA | Current |
| 55289-736 | SKELAXIN | metaxalone | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 55289-736 | SKELAXIN | metaxalone | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 55289-736 | SKELAXIN | metaxalone | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 55289-736 | SKELAXIN | metaxalone | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 55289-736 | SKELAXIN | metaxalone | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 60793-136 | SKELAXIN | metaxalone | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 60793-136 | SKELAXIN | metaxalone | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 61919-346 | METAXALONE | METAXALONE | DIRECT RX | NDA | Current |
| 61919-346 | METAXALONE | METAXALONE | DIRECT RX | NDA | Current |
| 63629-2768 | Metaxalone | Metaxalone | Bryant Ranch Prepack | NDA | Current |
| 64720-321 | Metaxalone | Metaxalone | CorePharma, LLC | NDA | Current |
| 64720-321 | Metaxalone | Metaxalone | CorePharma, LLC | NDA | Current |
| 68151-4668 | Metaxalone | Metaxalone | Carilion Materials Management | NDA | Current |
| 68258-7100 | Metaxalone | Metaxalone | Dispensing Solutions, Inc. | NDA | Current |
| 68788-0881 | Skelaxin | Metaxalone | Preferred Pharmaceuticals, Inc | NDA | Current |
| 68788-9896 | Metaxalone | Metaxalone | Preferred Pharmaceuticals, Inc. | NDA | Current |
| 70518-1161 | Metaxalone | Metaxalone | REMEDYREPACK INC. | NDA | Current |
| 70518-1161 | Metaxalone | Metaxalone | REMEDYREPACK INC. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 78879 | SUPPL | 2024-06-24 |
| 78871 | SUPPL | 2024-06-24 |
| 52908 | SUPPL | 2018-03-12 |
| 52874 | SUPPL | 2018-03-08 |
| 33103 | SUPPL | 2012-11-27 |
| 40686 | SUPPL | 2009-09-14 |
| 40685 | SUPPL | 2009-09-14 |
| 40684 | SUPPL | 2009-09-14 |
| 20043 | SUPPL | 2009-09-14 |
| 20041 | SUPPL | 2009-09-14 |
| 12045 | SUPPL | 2008-11-03 |
| 33102 | SUPPL | 2006-12-04 |
| 12044 | SUPPL | 2006-12-04 |
| 20042 | SUPPL | 2006-05-10 |
| 10831 | SUPPL | 2002-08-30 |
| 355 | SUPPL | 2002-08-30 |
| 356 | SUPPL | 2002-06-20 |